{"blog": [], "keywords": [{"value": "Abbott Laboratories", "name": "organizations", "rank": "1", "is_major": "N"}, {"value": "St Jude Medical Inc", "name": "organizations", "rank": "2", "is_major": "N"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Medical Devices", "name": "subject", "rank": "4", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/04/29/business/dealbook/investors-question-financial-sense-of-abbott-st-jude-deal.html", "document_type": "article", "byline": {"person": [{"lastname": "CYRAN", "firstname": "Robert", "role": "reported", "organization": "", "rank": 1}], "original": "By ROBERT CYRAN"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "301", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Abbott\u2019s $25 billion deal involves hefty borrowing and the company has another acquisition near. Will antitrust authorities allow the combination?", "pub_date": "2016-04-29T00:00:00Z", "news_desk": "Business", "headline": {"main": "Investors Question Financial Sense of Abbott-St. Jude Deal", "content_kicker": "Breakingviews"}, "print_page": null, "snippet": "Abbott\u2019s $25 billion deal involves hefty borrowing and the company has another acquisition near. Will antitrust authorities allow the combination?", "_id": "57223d6738f0d83c404739ba", "slideshow_credits": null, "abstract": null}